BIOSAFE

BIOSAFE

Biosafe manufactures patented polymers that improve performance in personal care, consumer, and healthcare products. Learn more

Launch date
Market cap
-
Enterprise valuation
$600—900k (Dealroom.co estimates Oct 2012.)
East Hartford Connecticut (HQ)
  • Edit
DateInvestorsAmountRound
-

N/A

-

N/A

Seed
N/A

$30.0k

Convertible

$100k

Seed
N/A

$150k

Seed

N/A

Acquisition
Total Funding$280k

Recent News about BIOSAFE

Edit
More about BIOSAFEinfo icon
Edit

Biosafe, Inc. specializes in advanced antimicrobial solutions designed to enhance the longevity and hygiene of various products. Utilizing innovative organosilicon technology, Biosafe's antimicrobial additives are more cost-effective and faster-acting than traditional silver-based alternatives. These additives are non-leaching, avoiding discoloration and preventing microbial resistance by puncturing and rupturing cell walls rather than metabolizing within the cell.

The company serves a diverse range of clients, including those in the medical, food service, and aerospace industries. Its primary market includes manufacturers of surface sprays, coatings, and liquid formulations, as well as companies requiring microbial protection for beverage tubing and other applications.

Biosafe operates on a B2B (business-to-business) model, generating revenue through the sale of its antimicrobial additives to manufacturers and industry partners. Key partnerships include collaborations with Certainty Technologies, National Wiper Alliance, CrossTex, and King Plastics, which leverage Biosafe's technology to enhance their own product offerings.

Keywords: antimicrobial solutions, organosilicon technology, non-leaching, bacteriostatic, fungistatic, algistatic, surface sprays, coatings, liquid formulations, beverage tubing.

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.